High‐Throughput Single Nucleotide Polymorphisms Genotyping Technologies

KU Chee Seng, National University of Singapore, Singapore
KASIMAN Katherine, National University of Singapore, Singapore
CHIA Kee Seng, National University of Singapore, Singapore

Published online: September 2009

DOI: 10.1002/9780470015902.a0021631

Genome-wide association studies have successfully identified many novel genetic loci for various human complex diseases and quantitative traits. There are several important factors contributing to the feasibility of this approach; one of them is the rapid advancement in high-throughput single nucleotide polymorphisms (SNPs) genotyping technologies which has enabled researchers to comprehensively interrogate the entire human genome. Almost all the studies that have been published up to date used commercially available whole-genome genotyping arrays from Illumina® and Affymetrix®. The most prominent feature of these high-throughput genotyping platforms is the ability to interrogate several hundred thousands to one million SNPs simultaneously in a microarray. The application of genotyping arrays is not only limited to association studies, but it has also been applied to many other human genetic studies. However, the rapid developments of sequencing technologies have started replacing the microarray experiments for both structural and functional genomics studies.

Key concepts:

  • Over the past three years, GWAS have been playing an important role in identifying novel genetic loci for various human complex diseases and quantitative traits.
  • The paradigm shift in genetic approach to GWAS has been attributed to several important developments, notably the rapid advancement in high-throughput SNPs genotyping technologies.
  • High-throughput SNPs genotyping technologies had enabled researchers to interrogate several hundred thousands to one million SNPs simultaneously in a microarray.
  • GWAS is a comprehensive and agnostic approach in the search for unknown disease variants, as such; the ability to interrogate large number of SNPs covering the entire human genome is a prerequisite to this study design.
  • Currently, Illumina® and Affymetrix® are the only two companies in the market who design and provide whole-genome genotyping arrays for human genetic studies.
  • There are two commonly adopted approaches in SNPs selection for whole-genome genotyping arrays: direct and indirect. Direct approach focuses on selecting SNPs that are of putative functional importance. In contrast, indirect approach selects SNPs despite their functionality.
  • Genome coverage is an estimate of the proportion of SNPs (using the International HapMap data as reference) that can be captured by the SNPs which directly genotyped in an array with a preset r2 threshold.
  • Expeditious developments of sequencing technologies have started threatening the market of microarray.
  • Currently, the three next-generation sequencing platforms are Illumina® Genome Analyzer, Roche® 454 GS-FLX Sequencer and ABI® SOLiD Sequencer.
  • Sequencing approach has been quickly adopted for various applications in structural and functional genomic studies, for example, ChIP-Seq, transcriptome profiling (RNA-Seq) and paired-end sequencing method to detect structural variations.

Keywords: single nucleotide polymorphisms; high-throughput genotyping technologies; illumina; affymetrix; genome coverage

Figure 1. Comparisons of genome coverage across several whole-genome genotyping arrays from Illumina® and Affymetrix® in International HapMap populations. The y-axis is the genome coverage in percentage. (see Li et al., (2008b); Barrett and Cardon, (2006)).
close
 References
    Barrett JC and Cardon LR (2006) Evaluating coverage of genome-wide association studies. Nature Genetics 38: 659–662.
    Bentley DR, Balasubramanian S, Swerdlow HP et al. (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456: 53–59.
    Bhangale TR, Rieder MJ and Nickerson DA (2008) Estimating coverage and power for genetic association studies using near-complete variation data. Nature Genetics 40: 841–843.
    Campbell PJ, Stephens PJ, Pleasance ED et al. (2008) Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genetics 40: 722–729.
    Carlson CS, Eberle MA, Rieder MJ et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. American Journal of Human Genetics 74: 106–120.
    Cooper GM, Johnson JA, Langaee TY et al. (2008a) A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood 112: 1022–1027.
    Cooper GM, Zerr T, Kidd JM et al. (2008b) Systematic assessment of copy number variant detection via genome-wide SNP genotyping. Nature Genetics 40: 1199–1203.
    Easton DF and Eeles RA (2008) Genome-wide association studies in cancer. Human Molecular Genetics 17: R109–R1115.
    Eberle MA, Ng PC, Kuhn K et al. (2007) Power to detect risk alleles using genome-wide tag SNP panels. PLoS Genetics 3: 1827–1837.
    Gunderson KL, Kuhn KM, Steemers FJ et al. (2006) Whole-genome genotyping of haplotype tag single nucleotide polymorphisms. Pharmacogenomics 7: 641–648.
    Gunderson KL, Steemers FJ, Lee G et al. (2005) A genome-wide scalable SNP genotyping assay using microarray technology. Nature Genetics 37: 549–554.
    Hao K, Schadt EE and Storey JD (2008) Calibrating the performance of SNP arrays for whole-genome association studies. PLoS Genetics 4: e1000109.
    Hunter DJ and Kraft P (2008) Drinking from the fire hose – statistical issues in genomewide association studies. New England Journal of Medicine 357: 436–439.
    International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437: 1299–1320.
    International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851–861.
    Jakobsson M, Scholz SW, Scheet P et al. (2008) Genotype, haplotype and copy-number variation in worldwide human populations. Nature 451: 998–1003.
    Johnson DS, Mortazavi A, Myers RM et al. (2007) Genome-wide mapping of in vivo protein–DNA interactions. Science 316: 1497–1502.
    Jorgenson E and White JS (2006) A gene-centric approach to genome-wide association studies. Nature Reviews Genetics 7: 885–891.
    Kennedy GC, Matsuzaki H, Dong S et al. (2003) Large-scale genotyping of complex DNA. Nature Biotechnology 21: 1233–1237.
    Klein RJ, Zeiss C, Chew EY et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385–389.
    Kong A, Thorleifsson G, Stefansson H et al. (2008) Sequence variants in the RNF212 gene associate with genome-wide recombination rate. Science 319: 1398–1401.
    Korbel JO, Urban AE, Affourtit JP et al. (2007) Paired-end mapping reveals extensive structural variation in the human genome. Science 318: 420–426.
    Ku CS and Chia KS (2008) The success of the genome-wide association approach: a brief story of a long struggle. European Journal of Human Genetics 16: 554–564.
    Lettre G and Rioux JD (2008) Autoimmune diseases: insights from genome-wide association studies. Human Molecular Genetics 17: R116–R121.
    Li JZ, Absher DM, Tang H et al. (2008a) Worldwide human relationships inferred from genome-wide patterns of variation. Science 319: 1100–1104.
    Li M, Li C and Guan W (2008b) Evaluation of coverage variation of SNP chips for genome-wide association studies. European Journal of Human Genetics 16: 635–643.
    Lundmark PE, Liljedahl U, Boomsma DI et al. (2008) Evaluation of HapMap data in six populations of European descent. European Journal of Human Genetics 16: 1142–1150.
    Magi R, Pfeufer A, Nelis M et al. (2007) Evaluating the performance of commercial whole-genome marker sets for capturing common genetic variation. BMC Genomics 8: 159.
    Mardis ER (2008) The impact of next-generation sequencing technology on genetics. Trends in Genetics 24: 133–141.
    Matsuzaki H, Dong S, Loi H et al. (2004a) Genotyping over 100 000 SNPs on a pair of oligonucleotide arrays. Nature Methods 1: 109–111.
    Matsuzaki H, Loi H, Dong S et al. (2004b) Parallel genotyping of over 10 000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Research 14: 414–425.
    McCarroll SA, Kuruvilla FG, Korn JM et al. (2008) Integrated detection and population-genetic analysis of SNPs and copy number variation. Nature Genetics 40: 1166–1174.
    Melzer D, Perry JR, Hernandez D et al. (2008) A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genetics 4: e1000072.
    Mohlke KL, Boehnke M and Abecasis GR (2008) Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Human Molecular Genetics 17: R102–R108.
    Redon R, Ishikawa S, Fitch KR et al. (2006) Global variation in copy number in the human genome. Nature 444: 444–454.
    Schadt EE, Molony C, Chudin E et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biology 6: e107.
    Shen F, Huang J, Fitch KR et al. (2008) Improved detection of global copy number variation using high density, non-polymorphic oligonucleotide probes. BMC Genetics 9: 27.
    Steemers FJ, Chang W, Lee G et al. (2006) Whole-genome genotyping with the single-base extension assay. Nature Methods 3: 31–33.
    Steemers FJ and Gunderson KL (2007) Whole genome genotyping technologies on the BeadArray platform. Biotechnology Journal 2: 41–49.
    Stefansson H, Rujescu D, Cichon S et al. (2008) Large recurrent microdeletions associated with schizophrenia. Nature 455: 232–236.
    Sultan M, Schulz MH, Richard H et al. (2008) A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321: 956–960.
    Wang J, Wang W, Li R et al. (2008) The diploid genome sequence of an Asian individual. Nature 456: 60–65.
    Weiss LA, Shen Y, Korn JM et al. (2008) Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine 358: 667–675.
    Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 447: 661–678.
    Xing J, Witherspoon DJ, Watkins WS et al. (2008) HapMap tagSNP transferability in multiple populations: general guidelines. Genomics 92: 41–51.
 Further Reading
    De la Vega FM, Lazaruk KD, Rhodes MD et al. (2005) Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP genotyping assays and the SNPlex genotyping system. Mutation Research 573: 111–135.
    Fan JB, Chee MS and Gunderson KL (2006) Highly parallel genomic assays. Nature Reviews Genetics 7: 632–644.
    Olivier M (2005) The invader assay for SNP genotyping. Mutation Research 573: 103–110.
    Ragoussis J, Elvidge GP, Kaur K et al. (2006) Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry in genomics research. PLoS Genetics 2: e100.
    Syvänen AC (2005) Toward genome-wide SNP genotyping. Nature Genetics 37: S5–S10.

Related Sub-Topics:

Techniques and Tools in Clinical Genetics | Linkage Analysis | Gene Mapping by Disease Association | Bioinformatics and Genetic Disease
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: High‐Throughput Single Nucleotide Polymorphisms Genotyping Technologies
 
How to Cite close
Chee Seng, KU, Katherine, KASIMAN, and Kee Seng, CHIA(Sep 2009) High‐Throughput Single Nucleotide Polymorphisms Genotyping Technologies. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0021631]